What do people with glaucoma know about their condition? A comparative cross-sectional incidence and prevalence survey

Clinical & Experimental Ophthalmology
Helen V Danesh-MeyerGreg D Gamble

Abstract

To assess and compare glaucoma knowledge between patients with established glaucoma, newly diagnosed glaucoma and the general population. 208 glaucoma patients, 100 newly diagnosed glaucoma patients from three clinical centres and 100 controls from non-ophthalmology outpatient clinics, were recruited and completed a validated self-administered true/false questionnaire assessing glaucoma knowledge. Demographic data were also recorded. Glaucoma knowledge score, out of a maximum of 22, and odds ratios (OR) with 95% confidence intervals (CI) of survey characteristics associated with falling in the lowest quartile of the overall knowledge score was evaluated for each study group. Established glaucoma patients had (median 17, interquartile range 15-19) marginally but significantly (P < 0.05) greater glaucoma knowledge scores than new patients (median 16, interquartile range 13-18). Both of these groups scored significantly better than the control population (median 13, interquartile range 10-14, P < 0.05). Significant misconceptions regarding glaucoma include: 80% of all participants thought that topical medications could not have systemic side-effects, 48% of established glaucoma patients believed symptoms would warn them of disease...Continue Reading

References

Oct 27, 1979·British Medical Journal·S E Norell
Jan 1, 1989·Eye·A J Elliott
Sep 15, 1985·American Journal of Ophthalmology·E M Spiritus, R Casciari
Jul 1, 1982·The British Journal of Ophthalmology·P A Granström
Feb 1, 1995·Australian and New Zealand Journal of Ophthalmology·P M LivingstonH R Taylor
May 1, 1996·Archives of Ophthalmology·M T YenE J Higginbotham
Dec 13, 1997·Australian and New Zealand Journal of Ophthalmology·K AtteboW Smith
Jan 30, 1999·The British Journal of Ophthalmology·P M LivingstonH R Taylor
Feb 26, 2000·Ophthalmology·A T GaschL R Pasquale
Mar 12, 2002·Clinical & Experimental Ophthalmology·John A LandersStuart L Graham
Dec 14, 2002·BMJ : British Medical Journal·James F KirwanRichard Wormald
Mar 19, 2003·The British Journal of Ophthalmology·S-M SawS Seah
Dec 23, 2003·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Sunil DeokuleSunil Shah
Jan 23, 2004·The British Journal of Ophthalmology·J F KirwanR Wormald
Mar 9, 2005·European Journal of Ophthalmology·J G M M HoevenaarsC A B Webers
Jan 4, 2006·American Journal of Ophthalmology·Leon W HerndonJane Neff Rollins
Feb 1, 2006·Acta Ophthalmologica Scandinavica·Juliette G M M HoevenaarsCarroll A B Webers
May 5, 2006·Clinical & Experimental Ophthalmology·Stuart C CarrollHelen V Danesh-Meyer
Jun 27, 2006·Investigative Ophthalmology & Visual Science·Jonathan S BhargavaAnthony J King

❮ Previous
Next ❯

Citations

Aug 26, 2009·Clinical & Experimental Ophthalmology·Xueli ChenXinghuai Sun
Aug 26, 2009·Clinical & Experimental Ophthalmology·Xiangmei KongWenyi Guo
Jan 18, 2015·Wiener klinische Wochenschrift·Sonja FabjaniVeronika Pia Vécsei-Marlovits
May 28, 2016·Ocular Immunology and Inflammation·Efrosini PapagiannuliPhilip I Murray
Dec 15, 2016·Seminars in Ophthalmology·Esteban PeraltaJullia A Rosdahl
Jul 12, 2017·Clinical & Experimental Ophthalmology·Simon E SkalickyUNKNOWN Glaucoma Australia Educational Impact Study Contributors
Feb 6, 2018·Journal of Glaucoma·Gustavo GameiroVittorio Porciatti
Feb 23, 2008·Clinical & Experimental Ophthalmology·George L Spaeth
Dec 15, 2011·European Journal of Ophthalmology·Georgios LabirisVassilios P Kozobolis
Jan 29, 2019·Thyroid : Official Journal of the American Thyroid Association·Matthew R Edmunds, Kristien Boelaert
Dec 19, 2020·Journal of Glaucoma·Ashley OomsAlbert S Khouri
Mar 20, 2021·Ocular Immunology and Inflammation·Claire M MuellerGhazala A Datoo O'Keefe
Feb 26, 2009·Current Opinion in Ophthalmology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.